Results 41 to 50 of about 1,625,836 (186)

Venous thromboembolism among elderly patients treated with atypical and conventional antipsychotic agents.

open access: yes, 2005
Some antipsychotic agents have been indicated as a possible risk factor for venous thromboembolism (VTE) in adult patients with psychiatric disorders. The aim of this study was to estimate the effect of atypical and conventional antipsychotic agents on ...
Kate L. Lapane   +9 more
core   +1 more source

Olanzapine-induced skin eruptions

open access: yesIndian Journal of Psychological Medicine, 2017
Adverse cutaneous reactions are known to occur with psychotropic medications, which may lead to poor drug compliance. As compared to other group of psychotropics, there is relatively scarce literature on olanzapine-induced skin eruptions.
Nishtha Chawla   +2 more
doaj   +1 more source

Duration of therapy and dose of individual antipsychotic agents by case patients with acute coronary syndrome and controls.

open access: yes, 2016
Duration of therapy and dose of individual antipsychotic agents by case patients with acute coronary syndrome and controls.
Hsing-Cheng Liu (438957)   +4 more
core   +1 more source

Psychotic Disorders: Self-Directed Learning Module

open access: yesMedEdPORTAL, 2014
Introduction Psychotic disorders, including schizophrenia, are listed among the ADMSEP Clinical Learning Objectives for Psychiatry Education of Medical Students (2007) and lead to significant morbidity, mortality, and healthcare burden for the patient ...
Sarah Johnson   +3 more
doaj   +1 more source

Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence? [PDF]

open access: yes, 2012
Background: Little is known about the factors influencing treatment choice in psychosis, the majority of this work being conducted with specialists (consultant) in psychiatry.
Nwachukwu Izu   +87 more
core   +2 more sources

Discharge and Readmission Rates with Atypical Antipsychotic Agents

open access: yes, 2002
Objective Newer atypical antipsychotic agents offer many advantages over conventional antipsychotic agents, including a decreased adverse effect burden, improved compliance, and superior efficacy.
Jessica L Goren, Gary M Levin
core   +1 more source

Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression

open access: yesDrug Design, Development and Therapy, 2016
Dawn Bruijnzeel, Rajiv Tandon Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL, USA Abstract: Antipsychotic agents, utilized for the treatment of a range of psychiatric disorders, differ substantially in terms of ...
Bruijnzeel D, Tandon R
doaj  

Prevalence of and factors associated with antipsychotic polypharmacy in patients with serious mental illness: Findings from a cross-sectional study in an upper-middle-income country

open access: yesBrazilian Journal of Psychiatry
Objective: The aim of our study was to examine the prevalence of and factors associated with antipsychotic polypharmacy (APP) among patients with serious mental illness in the current South African health care context.
Kerryn S. Armstrong, Henk Temmingh
doaj   +1 more source

Practical Guidance for the Use of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia

open access: yesPsychology Research and Behavior Management, 2022
Ilaria Riboldi,1 Daniele Cavaleri,1 Chiara A Capogrosso,1 Cristina Crocamo,1 Francesco Bartoli,1 Giuseppe Carrà1,2 1Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; 2Division of Psychiatry, University College London, London,
Riboldi I   +5 more
doaj  

Seizure Activity Associated with Antipsychotic Therapy

open access: yes, 1990
Approximately one percent of patients receiving antipsychotic medications develop seizure activity. In addition, approximately seven percent of epileptic patients develop chronic psychosis requiring antipsychotic treatment.
Barbara G. Wells   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy